Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial

Anke Lenferink, Job van der Palen, Paul D.L.P.M. van der Valk, Paul Cafarella, Anneke van Veen, Stephen Quinn, Catharina G.M. Groothuis-Oudshoorn, Morton G. Burt, Mary Young, Peter A. Frith, Tanja W. Effing

Source: Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018
Journal Issue: November
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Anke Lenferink, Job van der Palen, Paul D.L.P.M. van der Valk, Paul Cafarella, Anneke van Veen, Stephen Quinn, Catharina G.M. Groothuis-Oudshoorn, Morton G. Burt, Mary Young, Peter A. Frith, Tanja W. Effing. Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial. Eur Respir J, 54 (5) 1802134; 10.1183/13993003.02134-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
Source: ERJ Open Res, 5 (2) 00072-2019; 10.1183/23120541.00072-2019
Year: 2019



ß-blockers in exacerbations of COPD: feasibility of a randomised controlled trial
Source: ERJ Open Res, 3 (1) 00090-2016; 10.1183/23120541.00090-2016
Year: 2017



Effectiveness of an individualized action plan on health status recovery in patients with COPD: A randomized controlled trial
Source: Annual Congress 2010 - Pulmonary rehabilitation and chronic care: new developments in interventions, assessment and care
Year: 2010


Cardiac impact of inhaled therapy in the largest randomised placebo-controlled trial in COPD history: have we reached the SUMMIT?
Source: ERJ Open Res 2016: 00055-2016
Year: 2016



Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial
Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care
Year: 2011


Run-in bias in randomised trials: the case of COPD medications
Source: Eur Respir J, 49 (6) 1700361; 10.1183/13993003.00361-2017
Year: 2017



A self-management programme for COPD: a randomised controlled trial
Source: Eur Respir J 2014; 44: 1538-1547
Year: 2014



Predictors of long-term smoking cessation in patients with COPD: results from a randomised controlled trial
Source: Eur Respir J, 49 (6) 1700561; 10.1183/13993003.00561-2017
Year: 2017



The role of phonophoresis in patients with COPD: a randomized clinical trial
Source: Virtual Congress 2020 – Clinical and basic pharmacology for COPD
Year: 2020


Lower incidence of asthma exacerbations with FENO-guided anti-inflammatory treatment: A randomised controlled trial
Source: Annual Congress 2012 - Effectiveness of respiratory disease management in primary care
Year: 2012


Efficacy and costs of telehealth for the management of COPD: PROMETE II, a multicentre, randomized controlled trial
Source: International Congress 2017 – New trends in pulmonary rehabilitation and chronic care
Year: 2017



Evidence generation for the clinical impact of myCOPD in patients with mild, moderate and newly diagnosed COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (4) 00460-2020; 10.1183/23120541.00460-2020
Year: 2020



Can simvastatin reduce COPD exacerbations? A randomised double-blind controlled study
Source: Eur Respir J, 58 (1) 2001798; 10.1183/13993003.01798-2020
Year: 2021



Effect of ADL- training for persons with COPD: A randomized controlled trial
Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD
Year: 2011


Effectiveness of a pharmacist-led inhalation technique intervention on asthma and COPD patients: The INspira cluster-randomized controlled trial
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021



A prospective randomised double-blind placebo controlled trial of venlafaxine in patients with stable chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 32s
Year: 2006

Effect of telehealthcare on exacerbations and hospital admissions in COPD: A randomised controlled trial
Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care
Year: 2015


Acute effects of nasal high-flow during exercise in COPD patients after an exacerbation : a randomized controlled cross-over trial
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019

Early pulmonary rehabilitation after acute exacerbation of COPD: a randomised controlled trial
Source: ERJ Open Res, 6 (1) 00173-2019; 10.1183/23120541.00173-2019
Year: 2020



Roflumilast for stable COPD: Meta-analysis of randomized controlled trials
Source: International Congress 2014 – Clinical presentations
Year: 2014